Literature DB >> 31807548

Application of endobronchial ultrasonography using a guide sheath and electromagnetic navigation bronchoscopy in the diagnosis of atypical bacteriologically-negative pulmonary tuberculosis.

Ye Gu1, Chunyan Wu2, Fangyou Yu3, Xuwei Gui4, Jun Ma4, Liping Cheng4, Qin Sun4, Wei Sha4.   

Abstract

BACKGROUND: In the absence of a positive sputum bacteriological result, pathological and bacteriological examinations of lung lesion biopsies are important methods to confirm bacteriological-negative tuberculosis. Endobronchial ultrasonography with guide sheath (EBUS-GS) and electromagnetic navigation bronchoscopy (ENB) are two new endobronchial diagnostic techniques, the combination of which has greatly facilitated the diagnosis of peripheral pulmonary lesions and is an especially useful, minimally invasive, effective diagnostic method for bacteriologically-negative tuberculosis cases.
METHODS: A total of 78 patients were included in this study with suspected pulmonary tuberculosis based on clinical manifestations, laboratory tests, and imaging studies. The patients underwent a high-resolution chest CT scan before bronchoscopy, A method was selected (EBUS-GS alone, or EBUS-GS + ENB) based on the lesion site and the level and angle of the bronchus involved. After the lesion was found, a puncture needle, biopsy forceps, and brushing forceps were used to collect a tissue sample.
RESULTS: Forty-four patients were diagnosed with tuberculosis; 1, nontuberculous Mycobacteria (NTM) lung disease; 15, lung cancer; 15, pulmonary infection; 1, allergic bronchopulmonary aspergillosis (ABPA); and 2, pneumoconiosis. A total of 25 patients of TB (56.8%) were successfully diagnosed with EBUS-GS plus ENB. Among the patients with confirmed diagnosis, 9 were diagnosed with pathological examination; 4, genetic analysis; 11, positive smear; and 14, positive culture.
CONCLUSIONS: The introduction of EBUS and ENB in China has provided a new direction for the diagnosis of atypical bacteriological-negative tuberculosis, as the techniques are less invasive and less expensive than thoracoscopy. 2019 Annals of Translational Medicine. All rights reserved.

Entities:  

Keywords:  Tuberculosis; diagnostics; electromagnetic navigation bronchoscopy (ENB); endobronchial ultrasonography with guide sheath (EBUS-GS)

Year:  2019        PMID: 31807548      PMCID: PMC6861774          DOI: 10.21037/atm.2019.09.37

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  19 in total

1.  Endobronchial ultrasonography using a guide sheath increases the ability to diagnose peripheral pulmonary lesions endoscopically.

Authors:  Noriaki Kurimoto; Teruomi Miyazawa; Seiji Okimasa; Akihiro Maeda; Hiroshi Oiwa; Yuka Miyazu; Masaki Murayama
Journal:  Chest       Date:  2004-09       Impact factor: 9.410

2.  Electromagnetic navigation bronchoscopy performed by thoracic surgeons: one center's early success.

Authors:  Daryl Phillip Pearlstein; Curtis C Quinn; Charles C Burtis; Kwang Woo Ahn; Aaron J Katch
Journal:  Ann Thorac Surg       Date:  2012-01-23       Impact factor: 4.330

3.  Electromagnetic navigation diagnostic bronchoscopy: a prospective study.

Authors:  Thomas R Gildea; Peter J Mazzone; Demet Karnak; Moulay Meziane; Atul C Mehta
Journal:  Am J Respir Crit Care Med       Date:  2006-07-27       Impact factor: 21.405

4.  Incremental yield of bronchial washing for diagnosing smear-negative pulmonary tuberculosis.

Authors:  Alonso Soto; Vilma Acurio; Lely Solari; Patrick Van der Stuyft
Journal:  Rev Saude Publica       Date:  2013-08       Impact factor: 2.106

5.  Diagnostic yield of electromagnetic navigation bronchoscopy is highly dependent on the presence of a Bronchus sign on CT imaging: results from a prospective study.

Authors:  Luis M Seijo; Juan P de Torres; María D Lozano; Gorka Bastarrika; Ana B Alcaide; Maria M Lacunza; Javier J Zulueta
Journal:  Chest       Date:  2010-04-30       Impact factor: 9.410

6.  Analysis of the internal structure of peripheral pulmonary lesions using endobronchial ultrasonography.

Authors:  Noriaki Kurimoto; Masaki Murayama; Shinkichiro Yoshioka; Takashi Nishisaka
Journal:  Chest       Date:  2002-12       Impact factor: 9.410

Review 7.  Electromagnetic navigational bronchoscopy.

Authors:  Jeffrey Port; Sebron Harrison
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

8.  Endobronchial ultrasound for tubercular mediastinal adenopathy and its comparison with traditional tools.

Authors:  A Dhamija; V B Ganga; A Guliani; R Raveendran; K Verma; A K Basu
Journal:  Int J Tuberc Lung Dis       Date:  2019-08-01       Impact factor: 2.373

9.  Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).

Authors:  Michael K Gould; James Fletcher; Mark D Iannettoni; William R Lynch; David E Midthun; David P Naidich; David E Ost
Journal:  Chest       Date:  2007-09       Impact factor: 9.410

10.  The introduction of electromagnetic navigation bronchoscopy for the diagnosis of small pulmonary peripheral lesions in an Asian population.

Authors:  Ye Gu; Shanhao Chen; Jingyun Shi; Chunyan Wu; Zongmei Wen; Hong Shi; Baomei Wu; Xin Xu; Hao Wang
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

View more
  3 in total

1.  CircAGFG1modulates autophagy and apoptosis of macrophages infected by Mycobacterium tuberculosis via the Notch signaling pathway.

Authors:  Qinghong Shi; Jingying Wang; Zhe Yang; Yang Liu
Journal:  Ann Transl Med       Date:  2020-05

2.  Effectiveness of Endobronchial Ultrasound-Guided Transbronchial Biopsy Combined With Tissue Culture for the Diagnosis of Sputum Smear-Negative Pulmonary Tuberculosis.

Authors:  Ching-Kai Lin; Hung-Jen Fan; Kai-Lun Yu; Lih-Yu Chang; Yueh-Feng Wen; Li-Ta Keng; Chao-Chi Ho
Journal:  Front Microbiol       Date:  2022-04-25       Impact factor: 5.640

3.  The efficacy of endobronchial valves for the treatment of bronchopleural fistula: a single-arm clinical trial.

Authors:  Xinmiao Song; Ye Gu; Hao Wang; Li Zhang
Journal:  J Thorac Dis       Date:  2022-03       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.